⚙️
🌟 Najlepsze dopasowanie
Wpisz szukaną frazę, aby zobaczyć propozycje AI.

Legal changes in the online sale of medicinal products

Legal changes in the online sale of medicinal products

As of May 3, 2015, a new regulation of the Minister of Health regarding the mail-order sale of medicinal products has entered into force. Will the new law eliminate counterfeit products from the market? What new obligations does the legislator impose on online pharmacies?

The new law concerns the mail-order sale of a medicinal product, which, according to the Pharmaceutical Law Act, is a substance or mixture of substances presented as having properties for preventing or treating diseases occurring in humans or animals, or administered for the purpose of making a diagnosis, or in order to restore, improve, or modify physiological functions of the body through pharmacological, immunological, or metabolic action.
The purpose of the new regulation of the Minister of Health on the mail-order sale of medicinal products is to adapt Polish law to European Union legislation, primarily in the context of preventing the introduction and distribution of falsified medicinal products. What do the new regulations concern?

New information obligations for e-pharmacies
The regulations entering into force on May 3, 2015, primarily regulate new information obligations for e-pharmacies. The following information must appear on the pharmacy’s website:
1. Information about the competent Provincial Pharmaceutical Inspectorate – name of the authority, physical address, e-mail address, and telephone or fax number. The regulation does not precisely specify where exactly on the website the WIF data should appear – it can be information in the Contact tab or another subpage linked from the footer.
2. A clear, common EU logo, linked on the website of an e-pharmacy registered with the WIF, conducting mail-order sales, and included in the list on the CSIOZ website. The minimum width of the logo should be 90 px.
3. A link to the Public Information Bulletin of the GIF, which should contain information, among other things, on the regulations governing mail-order sales in Poland or the risks associated with purchasing medicinal products online.
4. A link to the National Register of Permits for Operating Public Pharmacies, Pharmacy Points, and the Register of Granted Consents for Operating Hospital and Institutional Pharmacies.
5. Information for buyers that they are not entitled to privileges resulting from the Consumer Rights Act.

An e-pharmacy conducting mail-order sales should, preferably in the terms and conditions placed on the website or during the purchasing process, inform buyers that in the case of purchasing non-prescription drugs, they are not entitled to the right to return them without providing a specific reason.

– The return of a medicinal product to a pharmacy, in reference to Art. 96 sec. 6 of the Pharmaceutical Law Act, can only be made in the event of a quality defect of the product, its improper dispensing, or the falsification of the medicinal product. This provision has been standardized for both purchases in a traditional pharmacy and an e-pharmacy – explains Rafał Stępniewski from Rzetelnyregulamin.pl. – It should also be remembered that this provision does not apply to other products sold in e-pharmacies, such as dietary supplements or cosmetics.

The above change abolishes the burdensome and costly obligation to dispose of returned medicinal products. Previously, based on Art. 3 point 8 of the regulation of March 14, 2008, on the conditions for mail-order sale of medicinal products dispensed without a doctor’s signature, drugs acquired via mail order could be returned within 10 days from the date of delivery of the medicinal product, and the pharmacy, regardless of the reason, had to accept and dispose of such products. Another change introduced by the new regulations is the abolition of the pharmacy manager’s obligations regarding the approval of mail-order sales procedures. Under the new regulations, e-pharmacies are not required to prepare them.
The new regulation is intended to help more effectively prevent the practice of introducing and distributing falsified medicinal products and to make legally operating online pharmacies more credible in the eyes of consumers.